<DOC>
	<DOC>NCT03003143</DOC>
	<brief_summary>Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients</brief_summary>
	<brief_title>Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Hashimoto Disease</mesh_term>
	<mesh_term>Vigabatrin</mesh_term>
	<criteria>Age 1885 Possible autoimmune encephalitis Patients who have been diagnosed and treated for encephalitis for more than 4 weeks Patients with epilepsy (EEG finding or clinically) septic shock, fever &gt;38.5 â„ƒ, O2 saturation &lt;90%, respiratory rate &gt;25, HR &gt;120 previously, mRS=3 or mRS&gt;3 MMSE&lt;20 Patients who have terminal disease eye problem pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>